Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.4270 USD
−5.02 M USD
536.36 K USD
3.45 M
About Lipella Pharmaceuticals Inc.
Sector
Industry
CEO
Jonathan Kaufman
Website
Headquarters
Pittsburgh
Founded
2005
ISIN
US53630L2097
FIGI
BBG01C353VP8
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LIPO is 0.6280 USD — it has increased by 18.47% in the past 24 hours. Watch Lipella Pharmaceuticals Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Lipella Pharmaceuticals Inc. stocks are traded under the ticker LIPO.
LIPO stock has risen by 4.32% compared to the previous week, the month change is a 13.15% rise, over the last year Lipella Pharmaceuticals Inc. has showed a −97.85% decrease.
LIPO reached its all-time high on Dec 20, 2022 with the price of 494.0800 USD, and its all-time low was 0.5193 USD and was reached on Oct 10, 2025. View more price dynamics on LIPO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LIPO stock is 16.84% volatile and has beta coefficient of 0.33. Track Lipella Pharmaceuticals Inc. stock price on the chart and check out the list of the most volatile stocks — is Lipella Pharmaceuticals Inc. there?
Today Lipella Pharmaceuticals Inc. has the market capitalization of 2.90 M, it has decreased by −3.62% over the last week.
Yes, you can track Lipella Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Lipella Pharmaceuticals Inc. is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
LIPO net income for the last quarter is −1.33 M USD, while the quarter before that showed −1.31 M USD of net income which accounts for −1.60% change. Track more Lipella Pharmaceuticals Inc. financial stats to get the full picture.
No, LIPO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 18, 2025, the company has 7 employees. See our rating of the largest employees — is Lipella Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lipella Pharmaceuticals Inc. EBITDA is −5.59 M USD, and current EBITDA margin is −946.69%. See more stats in Lipella Pharmaceuticals Inc. financial statements.
Like other stocks, LIPO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lipella Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.